ClinicalTrials.Veeva

Menu

The Surveillance Clinical Study of Rickettsiosis

N

National Research Center for Epidemiology and Microbiology

Status

Enrolling

Conditions

Rickettsiosis

Study type

Observational

Funder types

Other

Identifiers

NCT06162975
01-RICK-2023

Details and patient eligibility

About

The purpose of this surveillance (non-interventional) clinical study is to genotype the causative agents of rickettsiosis in biological samples of patients from the Altai Republic, Russian Federation. This is a solely observational study in the patients with diagnosed or suspected tick-borne rickettsioses, with no intervention to the routine treatment and diagnostic process. During the study the medical history, diseases progress and symptoms, as well as treatments are being registered in individual case report forms. The rests of the samples used for standard diagnostics (plasma, or serum, and/or swabs of the tick bite site) are being collected and afterwards will be analyzed for a new rickettsia type. These data will be compared to the medical history and symptoms of the patients in order to identify clinical pattern specific for the new rickettsia type. Informed consents from all patients or their legal representatives are being collecting. The study was approved by the local ethical committee.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written patient's informed concent for study participation;
  • Male and female patients of any age with diagnosed or suspected tick-born rickettsioses.

Exclusion criteria

  • Unwillingness to participate in the study by any reason.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems